| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.25 | 1e-13 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.25 | 2e-13 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.23 | 7e-13 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.22 | 3e-11 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-10 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-10 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.21 | 1e-09 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.22 | 2e-09 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.3 | 2e-09 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.23 | 2e-09 |